Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.
about
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortiumUnraveling insulin-like growth factor binding protein-3 actions in human diseaseEpithelial cancers in the post-genomic era: should we reconsider our lifestyle?A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease riskIGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.Can genes for mammographic density inform cancer aetiology?Assessment of age-related changes in heritability and IGF-1 gene effect on circulating IGF-1 levels.IGF-I during primiparous pregnancy and maternal risk of breast cancerCirculating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the communityA comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among CaucasiansThe Association between IGF-1 Polymorphisms, IGF-1 Serum Levels, and Cognitive Functions in Healthy Adults: The Amsterdam Growth and Health Longitudinal Study.Association of physical activity with hormone receptor status: the Shanghai Breast Cancer StudyGenetic and dietary determinants of insulin-like growth factor (IGF)-1 and IGF binding protein (BP)-3 levels among Chinese women.Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancerA prospective study of physical activity and breast cancer incidence in African-American women.Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.A microsatellite polymorphism in IGF1 gene promoter and timing of natural menopause in Caucasian womenChanges in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women.Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.Obesity alters gene expression for GH/IGF-I axis in mouse mammary fat pads: differential role of cortistatin and somatostatin.Role of traditional and new biomarkers in breast carcinogenesis.Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer riskDietary fat, fiber, and carbohydrate intake and endogenous hormone levels in premenopausal womenCommon genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.IGFBP3 mRNA expression in benign and malignant breast tumorsEffects of High-Order Interactions among IGFBP-3 Genetic Polymorphisms, Body Mass Index and Soy Isoflavone Intake on Breast Cancer Susceptibility.Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans.Exercise-induced lung cancer regression: mechanistic findings from a mouse modelGenetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancerAbsence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women.Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).Neonatal growth and breast cancer risk in adulthood.Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk.Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women.Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.Cloning and expression of full-length human insulin-like growth factor binding protein 3 (IGFBP3) in the Escherichia coli.Birth weight and subsequent risk of cancer.
P2860
Q24614574-1F26AFAC-3C7D-4649-B76A-9B10BED30F3DQ24650060-DA7E3B44-BDC5-4E50-8DEC-D7C6817CD354Q28391921-93F1FA37-9865-4EC9-BDB3-E4671595AAFBQ31013593-3D2934A2-76A6-4C84-985A-42E4382431A3Q33348545-4B36150C-F88C-4CC9-9D51-3B2D976C1A2AQ33543396-86FD93C4-A789-465B-9402-6AC56363BAA9Q33635885-671D44AC-33F5-42D4-ADE5-2DB4DE2F1A88Q33848720-89D5C83B-A69E-4C3F-A553-9EECF43FC080Q33916778-6244EC98-D1CB-47BB-B1C5-428F9B7E94ADQ33936965-BC870335-D626-4C34-8437-494E538F5C3CQ33980349-457819E3-40CE-4A57-AE5B-E9B49F995B39Q33996744-A1932955-2DE1-47B4-94E5-D2E5884FF2B4Q34248104-2F6089D9-BCF2-46F7-B3BF-A590495C2C6BQ34294117-65B7E01C-1A62-4096-B901-08EF563C3A0EQ34328099-FBD9311D-7931-4782-A260-6EB06F36224AQ34338886-0975E02D-C3DF-49D3-980E-A9B86AB90F83Q34458312-4F1D9674-8ACD-44A6-BE55-35AF2C268DBFQ34636364-91251F42-BA3E-4B9C-AD4E-7C28D096EC70Q34784737-D727F39F-F637-40CC-AD30-50C3D3FA3AF3Q35034838-46FDE863-B857-4994-BDBE-DAEF4640CCEAQ35098547-4FE0D079-B566-4070-8159-9C254E701049Q35217246-05E770E1-59E5-45E8-8F0B-000492621F85Q35572905-4FF41855-C857-491D-A53A-95A33200D9ACQ35615218-76550DC7-B08F-4D89-929A-3FEDCCA85938Q35659602-E35B9652-8E90-424A-9875-852F8474FA81Q35749326-E7E3CEEE-C96A-4627-B502-4147A0787C85Q35749398-88A7C34D-317B-4CDC-8FFA-C86D5EB686D3Q36134212-BC05A346-4DB7-41B8-8C1F-0BAF7BB8845DQ36322738-3C643543-3F00-46BB-ACE6-31154FC3199AQ36380474-213DF8B9-ED5C-45A6-82C7-AE2CD0476404Q36581469-8411EF5D-7549-49AE-989F-FE2CA7FF60A4Q36609959-C3C63E79-5B51-40F8-BBF0-4F1C498AA295Q36849912-8256D84F-C5CF-4256-83D2-218052A44327Q36965021-808C1C17-D05E-47EE-86DC-0FB98CA2E6A8Q36978703-ED634544-BD1B-4512-BEF5-47D14CAA5B71Q37090766-7E255EFD-03C1-4E94-A445-6E6681639751Q37137519-4E63E84F-13E6-4500-BF50-7D8A593D4A22Q37441195-F8B5A9E6-A0EB-444B-B9CE-7CB894FBC1FDQ39260731-2D75EDC9-EF32-4856-AE10-96274F30A356Q51805391-4640F713-A484-4429-9E9B-490BC8E15516
P2860
Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Polymorphisms and circulating ...... t cancer: a systematic review.
@ast
Polymorphisms and circulating ...... t cancer: a systematic review.
@en
Polymorphisms and circulating ...... t cancer: a systematic review.
@nl
type
label
Polymorphisms and circulating ...... t cancer: a systematic review.
@ast
Polymorphisms and circulating ...... t cancer: a systematic review.
@en
Polymorphisms and circulating ...... t cancer: a systematic review.
@nl
prefLabel
Polymorphisms and circulating ...... t cancer: a systematic review.
@ast
Polymorphisms and circulating ...... t cancer: a systematic review.
@en
Polymorphisms and circulating ...... t cancer: a systematic review.
@nl
P2093
P1476
Polymorphisms and circulating ...... st cancer: a systematic review
@en
P2093
Alan Ashworth
Dan R Altmann
Isabel Dos Santos Silva
Jeffrey M P Holly
Julian Peto
Lorna Gibson
Nichola Johnson
P577
2005-01-01T00:00:00Z